Eisai: Announcement About an Approval for Additional Indicat

Eisai: Announcement About an Approval for Additional Indication of Jyseleca, JAK inhibitor

Eisai: Announcement About an Approval for Additional Indication of Jyseleca, JAK inhibitor
jcnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jcnnewswire.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Japan , Tokyo , Kitasato , Japan General , Norifumi Hibi , Mamoru Watanabe , Eisai Co Ltd , Ea Pharma Co Ltd , Gilead Sciences , Japan Corporate News Network , Announcement About , Additional Indication , Janus Kinase , Advanced Treatment , Inflammatory Bowel Disease , Kitasato Institute Hospital , Tokyo Medical , Dental University , Japan Corporate News ,